Breaking News Instant updates and real-time market news.

OOMA

Ooma

$14.49

-0.45 (-3.01%)

16:20
05/21/19
05/21
16:20
05/21/19
16:20

Ooma narrows FY20 EPS view to (24c)-(19c) from (24c)-(14c), consensus (19c)

Raises FY20 revenue view to $145M-$148M from $140M-$143M, consensus $141.69M.

  • 21

    May

  • 05

    Jun

  • 10

    Jun

OOMA Ooma
$14.49

-0.45 (-3.01%)

11/28/18
11/28/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Spirit Airlines (SAVE) upgraded to Overweight from Neutral at JPMorgan with analyst Jamie Baker saying he admits to being "clearly misgauged" over the elasticity of Spirit's passenger base following the company's Q4 TRASM outlook "surprise." 2. Ooma (OOMA) upgraded to Outperform from Market Perform at William Blair with analyst Bhavan Suri saying the "solid" quarter shows Ooma's "consistent execution." 3. DaVita (DVA) upgraded to Outperform from Market Perform at Raymond James with analyst John Ransom saying the stock has fallen about 18% since the company reported a Q3 earnings miss and since the defeat of the California ballot initiative, creating an attractive entry point. 4. Aspen Technology (AZPN) upgraded to Buy from Hold at Canaccord with analyst David Hynes citing valuation. 5. Union Pacific (UNP) upgraded to Buy from Hold at Deutsche Bank with analyst Amit Mehrotra saying after several years of "weak" cost control, Union Pacific is now positioned for at least $3B in profit improvement. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/28/18
WBLR
11/28/18
UPGRADE
WBLR
Outperform
Ooma upgraded to Outperform from Market Perform at William Blair
William Blair analyst Bhavan Suri upgraded Ooma to Outperform following the company's Q3 results. The "solid" quarter shows Ooma's "consistent execution," Suri tells investors in a research note. Further, the stock's multiple is currently less than half that of the peer group, which makes now an attractive time to buy the stock, says the analyst.
08/23/18
RILY
08/23/18
NO CHANGE
Target $20
RILY
Buy
Ooma price target raised to $20 from $15.50 at B. Riley FBR
B. Riley FBR analyst Josh Nichols raised his price target for Ooma to $20 ahead of the company's Q2 results on August 28. The company's expanding UCaaS and home security platform should support subscription growth, Nichols tells investors in a research note. The analyst keeps a Buy rating on the shares.
08/10/18
FBCO
08/10/18
INITIATION
Target $13
FBCO
Neutral
Ooma assumed with a Neutral at Credit Suisse
Target $13.

TODAY'S FREE FLY STORIES

KHC

Kraft Heinz

$30.51

-0.98 (-3.11%)

07:26
06/25/19
06/25
07:26
06/25/19
07:26
Periodicals
Buffett denies reports of tension between him, 3G over Kraft Heinz, CNBC reports »

Buffett says 3G's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$223.66

1.76 (0.79%)

07:26
06/25/19
06/25
07:26
06/25/19
07:26
Recommendations
Tesla analyst commentary  »

Oppenheimer continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$72.05

0.91 (1.28%)

, MCD

McDonald's

$203.92

-0.29 (-0.14%)

07:26
06/25/19
06/25
07:26
06/25/19
07:26
Upgrade
GrubHub, McDonald's, Starbucks rating change  »

Citi sees five reasons to…

GRUB

GrubHub

$72.05

0.91 (1.28%)

MCD

McDonald's

$203.92

-0.29 (-0.14%)

SBUX

Starbucks

$83.65

-0.16 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 26

    Jul

ERI

Eldorado Resorts

$45.86

-5.36 (-10.46%)

07:25
06/25/19
06/25
07:25
06/25/19
07:25
Conference/Events
Eldorado Resorts to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

BPOP

Popular

$52.70

0.37 (0.71%)

07:23
06/25/19
06/25
07:23
06/25/19
07:23
Recommendations
Popular analyst commentary  »

Popular's valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

MYGN

Myriad Genetics

$23.04

-0.47 (-2.00%)

07:23
06/25/19
06/25
07:23
06/25/19
07:23
Hot Stocks
Myriad Genetics announces publication of EndoPredict cost effectiveness study »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 06

    Aug

  • 13

    Nov

HEXO

HEXO Corp

$5.35

-0.245 (-4.38%)

07:20
06/25/19
06/25
07:20
06/25/19
07:20
Downgrade
HEXO Corp rating change  »

HEXO Corp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVXL

Anavex

$3.25

-0.12 (-3.56%)

07:20
06/25/19
06/25
07:20
06/25/19
07:20
Hot Stocks
Anavex announces first patient dosed in Rett syndrome extension study »

Anavex announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANGI

Angi Homeservices

$14.38

-0.21 (-1.44%)

07:19
06/25/19
06/25
07:19
06/25/19
07:19
Recommendations
Angi Homeservices analyst commentary  »

Angi Homeservices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

BHF

Brighthouse Financial

$38.10

-0.01 (-0.03%)

07:19
06/25/19
06/25
07:19
06/25/19
07:19
Downgrade
Brighthouse Financial rating change  »

Brighthouse Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGTC

Applied Genetic

$3.80

-0.145 (-3.68%)

, AERI

Aerie Pharmaceuticals

$30.21

-0.7 (-2.26%)

07:18
06/25/19
06/25
07:18
06/25/19
07:18
Hot Stocks
Applied Genetic names Theresa Heah CMO, Brian Krex general counsel »

Applied Genetic (AGTC)…

AGTC

Applied Genetic

$3.80

-0.145 (-3.68%)

AERI

Aerie Pharmaceuticals

$30.21

-0.7 (-2.26%)

ALXN

Alexion

$126.92

-5.55 (-4.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 10

    Jul

  • 11

    Jul

  • 31

    Jul

  • 01

    Aug

MCHP

Microchip

$85.16

0.08 (0.09%)

07:16
06/25/19
06/25
07:16
06/25/19
07:16
Initiation
Microchip initiated  »

Microchip initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLAB

Silicon Labs

$96.26

-0.41 (-0.42%)

07:14
06/25/19
06/25
07:14
06/25/19
07:14
Initiation
Silicon Labs initiated  »

Silicon Labs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNC

Lincoln National

07:14
06/25/19
06/25
07:14
06/25/19
07:14
Upgrade
Lincoln National rating change  »

Lincoln National upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

TRI

Thomson Reuters

$65.83

-0.16 (-0.24%)

07:13
06/25/19
06/25
07:13
06/25/19
07:13
Downgrade
Thomson Reuters rating change  »

Thomson Reuters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$39.80

-1.26 (-3.07%)

07:13
06/25/19
06/25
07:13
06/25/19
07:13
Recommendations
Biohaven Pharmaceutical analyst commentary  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

SHW

Sherwin-Williams

$465.88

0.225 (0.05%)

07:13
06/25/19
06/25
07:13
06/25/19
07:13
Downgrade
Sherwin-Williams rating change  »

Sherwin-Williams…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 11

    Jul

ARVN

Arvinas

$21.81

(0.00%)

07:12
06/25/19
06/25
07:12
06/25/19
07:12
Hot Stocks
Arvinas announces FDA clearance of ARV-471 IND »

Arvinas announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$91.86

-1.78 (-1.90%)

07:11
06/25/19
06/25
07:11
06/25/19
07:11
Downgrade
Tiffany rating change  »

Tiffany SSS may prove…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:10
06/25/19
06/25
07:10
06/25/19
07:10
General news
FX Update: The dollar printed fresh lows »

FX Update: The dollar…

FDS

FactSet

$293.20

-4.89 (-1.64%)

07:10
06/25/19
06/25
07:10
06/25/19
07:10
Hot Stocks
FactSet increases share repurchase program by $210M »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

, AGN

Allergan

$129.65

-1.32 (-1.01%)

07:09
06/25/19
06/25
07:09
06/25/19
07:09
Conference/Events
AbbVie to host conference call »

Conference call to…

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

AGN

Allergan

$129.65

-1.32 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

NTRA

Natera

$24.69

-0.61 (-2.41%)

07:08
06/25/19
06/25
07:08
06/25/19
07:08
Recommendations
Natera analyst commentary  »

Natera price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$11.43

1.44 (14.41%)

, ERI

Eldorado Resorts

$45.86

-5.36 (-10.46%)

07:08
06/25/19
06/25
07:08
06/25/19
07:08
Downgrade
Caesars, Eldorado Resorts rating change  »

Caesars downgraded to…

CZR

Caesars

$11.43

1.44 (14.41%)

ERI

Eldorado Resorts

$45.86

-5.36 (-10.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 02

    Jul

FDS

FactSet

$293.20

-4.89 (-1.64%)

07:07
06/25/19
06/25
07:07
06/25/19
07:07
Earnings
FactSet raises FY19 adj. EPS view to $9.80-$9.90 from $9.50-$9.65 »

Consensus $9.59. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.